May 18, 2026 07:00AM
May 18, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 27, 2026 07:03AM
Apr 27, 2026 07:00AM
Feb 10, 2026 07:00AM
Jan 13, 2026 02:50PM AstraZeneca acquires Modella AI to expand oncology AI capabilities
Dec 2, 2025 09:18AM
Dec 2, 2025 09:18AM
Nov 10, 2025 02:31AM
Nov 9, 2025 04:33PM
Nov 6, 2025 07:02AM
Nov 6, 2025 07:00AM
Nov 6, 2025 07:00AM AstraZeneca's 9M and Q3 2025 Financial Results
Oct 7, 2025 07:00AM
Oct 7, 2025 07:00AM
Sep 17, 2025 07:06AM
Sep 17, 2025 07:05AM
Sep 17, 2025 06:49AM
Aug 30, 2025 10:19AM
Jul 29, 2025 07:00AM AstraZeneca results: H1 and Q2 2025
Jul 14, 2025 07:01AM
Jul 14, 2025 07:00AM
May 29, 2025 04:30PM
May 29, 2025 04:30PM
Apr 29, 2025 02:00AM
Mar 21, 2025 07:22AM
Mar 17, 2025 08:14AM AstraZeneca (AZN) to acquire EsoBiotec
Feb 6, 2025 07:00AM
Jan 23, 2025 02:18PM
Jan 22, 2025 08:30AM
Dec 24, 2024 09:30AM
Nov 12, 2024 07:00AM
Jul 25, 2024 07:00AM
Jul 25, 2024 05:25AM AstraZeneca (AZN) Tops Q2 EPS by 99c; offers guidance
Jul 15, 2024 05:55AM
Jun 4, 2024 04:18PM
May 30, 2024 07:07AM
May 29, 2024 04:07PM
May 2, 2024 07:00AM
Apr 25, 2024 02:00AM
Apr 1, 2024 07:00AM VOYDEYAâ„¢ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
Mar 25, 2024 07:00AM
Mar 19, 2024 07:00AM
Mar 19, 2024 04:13AM
Mar 14, 2024 03:42AM
Feb 22, 2024 08:19AM
Feb 8, 2024 02:03AM
Feb 6, 2024 09:00AM AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development
Dec 26, 2023 11:39AM

1,159,566 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All